Role of β-adrenergic receptors in the oral activity of Zinc-α2-Glycoprotein (ZAG)

Endocrinology

Volumn 153, Issue 10, 2012, Pages 4696-4704

  Russell, Steven T ^a   Tisdale, Michael J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTIOBESITY AGENT; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; DRINKING WATER; GLUCOSE; INSULIN; PROPRANOLOL; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIGESTION; DRUG EFFECT; DRUG PURIFICATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GLUCOSE TRANSPORT; GLUCOSE URINE LEVEL; INSULIN SENSITIVITY; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECTUM TEMPERATURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLEUS MUSCLE; URINARY EXCRETION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BODY TEMPERATURE; BODY WEIGHT; ESOPHAGUS; MICE; OBESITY; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; SEMINAL PLASMA PROTEINS;

EID: 84866771134     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1260     Document Type: Article

References (29)

1. Russell ST, Tisdale MJ 2010 Antidiabetic properties of zinc-α2- glycoprotein in ob/ob mice. Endocrinology 151:948-957
2. Delker SL, West Jr AP, McDermott L, Kennedy MW, Bjorkman PJ 2004 Crystallographic studies of ligand binding by zinc-α2-glycoprotein. J Struct Biol 148:205-213 (Pubitemid 39346009)
3. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ 1998 Purification and characterisation of a tumor lipid-mobilizing factor. Cancer Res 58:2353-2358 (Pubitemid 28252694)
4. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ 2004 Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. Biochim Biophys Acta 1636:59-68 (Pubitemid 38231005)
5. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, Tisdale MJ, Trayhurn P 2004 Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 101:2500-2505 (Pubitemid 38269340)
6. Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J, Trayhurn P, Bing C 2010 The adipokine zinc-α2-glycoprotein is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 72:334-341
7. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P 2005 Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 579:41-47 (Pubitemid 40023371)
8. Russell ST, Tisdale MJ 2005 The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 92:876-881 (Pubitemid 40462633)
9. Bailey CJ, Flatt PR, Atkins TW 1982 Influence of genetic background and age on the expression of the obsese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obes 6:11-21 (Pubitemid 12157286)
10. Russell ST, Hirai K, Tisdale MJ 2002 Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer 86:424-428 (Pubitemid 34185128)
11. Inokuma K, Okamatsu-Ogura Y, Omachi A, Matsushita Y, Kimura K, Yamashita H, Saito M 2006 Indispensable role of mitochondrial UCP1 for antiobesity effect of β3-adrenergic stimulation. Am J Physiol Endocrinol Metab 290:E1014-E1021
12. Liu X, Perusse F, Bukowiecki LJ 1998 Mechanism of the antidiabetic effects of the β3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Am J Physiol Regul Integr Comp Physiol 43: R1212-R1219
13. Lynch GS, Ryall JG 2008 Role of β-adrenoceptor signalling in skeletal muscle: Implications for muscle wasting and disease. Physiol Rev 88:729-767 (Pubitemid 351520091)
14. Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD 1989 Molecular characterisation of the human β3-adrenergic receptor. Science 245:1118-1121 (Pubitemid 19231821)
15. Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg AD, Ricquier D, Emorine LJ 1993 Tissue distribution of β3-sdrenergic receptor mRNA in man. J Clin Invest 91:344-349 (Pubitemid 23037290)
16. Manara L, Croci T, Landi M 1995 β(3)-Adrenergic receptors and intestinal motility. Fundam Clin Pharmacol 9:332-342
17. Fletcher DS, Candelore MR, Grujic D, Lowell BB, Luell S, Susulic VS, Macintyre DE 1998 Beta-3 adrenergic receptor antagonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta3-adrenergic receptor. J Pharmacol Exp Ther 287:720-724 (Pubitemid 29133675)
18. Sarma DN, Banwait K, Basak A, DiMarino AJ, Rattan S 2003 Inhibitory effect of β3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies. J Pharmacol Exp Ther 304:48-55 (Pubitemid 36008911)
19. Masuno H, Yamasaki N, Okuda H 1981 Purification and characterisation of a lipolytic factor (Toxohormone-L) from cell-free fluid of ascites sarcoma 180. Cancer Res 41:284-288 (Pubitemid 11218830)
20. Khan S, Tisdale MJ 1999 Catabolism of adipose tissue by a tumour-producing lipid-mobilising factor. Int J Cancer 80:444-447 (Pubitemid 29019634)
21. Nisoli E, Tonello C, Landi M, Carruba MO 1996 Functional studies of the first selective β3-adrenergic receptor antagonist SR59230A in rat brown adipocytes. Mol Pharmacol 49:7-14 (Pubitemid 26037321)
22. Leblais V, Pourgeaud F, Ivorra MD, Guilbert C, Marthan R, Muller B Role of α-adrenergic receptors in the effect of the β-adrenergic receptor ligands CGP 12177, Bupranolol and SR59230A, on the contraction of rat intrapulmonary artery. J Pharmacol Exp Ther 309:137-145
23. Bexis S, Docherty JR 2009 Role of α1- and β3-adrenoceptors in the modulation of SR59230A of the effects of MDMA on body temperature in the mouse. Br J Pharmacol 158:259-266
24. Mayr B, Montminy M 2001 Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609 (Pubitemid 33674011)
25. Mracek T, Gao D, Tzanavari T, Bao Y, Xiao X, Stocker C, Trayhurn P, Bing C 2010 Downregulation of zinc-α2-glycoprotein in adipose tissue and liver of ob/ob mice and by tumour necrosis factor-α in adipocytes. J Endocrinol 204:165-172
26. Gong FY, Zhang SJ, Ding JY, Zhu HJ, Pan H, Li NS, Shi YF 2009 Zinc-α2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes 33:1023-1030
27. Selva DM, Lecube A, Hernández C, Baena JA, Fort JM, Simó R 2009 Lower zinc-α2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 94:4499-4507
28. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978 (Pubitemid 29177345)
29. Robidoux J, Martin TL, Collins S 2004 β-Adrenergic receptors and regulation of energy expenditure: a family affair. Annu Rev Physiol Toxicol 44:297-323 (Pubitemid 38263843)